SB 526 establishes a grant program to fund tribal colleges in Montana developing community health aide and dental health aide training programs. The program provides up to $3 million per institution, including a $1 million startup grant and $500,000 annually for four years, to expand or create education programs qualifying graduates for federal certification. Tribal colleges receiving grants must report annually on program outcomes, including graduates, provider certifications, patient access metrics, and cost-effectiveness. The bill directly affects tribal colleges and aims to address healthcare disparities in American Indian and Alaska Native communities by increasing local provider capacity. It allocates $1.5 million from the general fund for the 2025-2027 biennium to support this initiative.
SB 475, introduced in Montana, proposes to ban vaccines containing aluminum as an ingredient for use or administration within the state. It requires vaccine manufacturers and distributors to submit implementation plans within one year, including timelines for removing aluminum-containing vaccines and distributing aluminum-free alternatives. The ban would take effect only after the health department certifies aluminum-free vaccines are available. The bill died in committee in May 2025 and was never enacted into law. It directly affects vaccine providers, manufacturers, and distributors operating in Montana.
SB 136 amends Montana's criminal code (Section 45-2-211, MCA) to state that a patient's consent to physician aid in dying is not a defense to a homicide charge against the physician. The bill defines "physician aid in dying" as a physician prescribing a lethal medication for the patient to self-administer, excluding standard comfort care or withholding life-sustaining treatment. This directly affects physicians who provide such aid, making their actions prosecutable as homicide if consent is claimed as a defense. The law takes effect July 1, 2025, and does not impact existing practices of comfort care or end-of-life treatment under Montana law.
SB 62 would end Montana's Medicaid expansion program for able-bodied adults by prohibiting new enrollments after August 31, 2025, while requiring the Department of Public Health and Human Services to seek a federal waiver to maintain funding for current participants. The bill directly affects individuals enrolled in Montana's Medicaid expansion program who are able-bodied adults, preventing them from joining after the 2025 deadline. Key mechanisms include a strict enrollment cutoff date, a requirement for the department to apply for federal funding continuity, and authorization to implement program integrity measures like biannual eligibility reviews. The bill does not change coverage for individuals with specific health needs or those already enrolled continuously before September 1, 2025.
SB 334 would have expanded Montana Medicaid eligibility to able-bodied adults under 65 with incomes at or below 100% of the federal poverty level, but only if they met community engagement requirements. Key provisions include mandating participation in workforce development programs (like job training in healthcare or cybersecurity) and requiring the state to seek federal waiver approval by December 2025. The bill also included measures like biannual eligibility reviews and lifetime benefit limits for this group. However, the bill died in process on May 23, 2025, after failing to advance beyond committee review.
SB 474 would have expanded school immunization exemptions in Montana to include religious exemptions and a new "personal medical informed consent" exemption requiring only a notarized statement. This new exemption would allow students to decline vaccines after consulting a healthcare provider (without needing a provider's signature), distinct from the existing medical exemption requiring a healthcare provider's written statement. The bill also amended school immunization laws (20-5-405 and 49-2-312) to prevent schools from being sued for injuries related to exempt students and to block overly burdensome exemption forms. The bill died in committee on May 23, 2025, and never became law.
SB 164 amends Montana's endangering the welfare of children law to prohibit specific medical treatments for children under 16. The bill bans surgical procedures, puberty blockers, and hormone therapies (like estrogen or testosterone) when used to alter a child's appearance or affirm a gender identity inconsistent with their biological sex. Violating this prohibition is classified as a felony, carrying up to five years in prison and a $10,000 fine, with harsher penalties if the child suffers serious injury. The law would take effect on January 1, 2026, directly affecting medical providers, caregivers, and children under 16 who might receive these treatments.
SB 479 proposes to revise Montana laws around chemical abortion by requiring health care providers to physically examine patients, be present during administration, schedule a follow-up within 7 days, and provide disposal kits (catch kits and medical waste bags) for patients to return used materials. It holds manufacturers of abortion drugs responsible for environmental cleanup if drug byproducts contaminate wastewater systems, with fines up to $20,000 per violation. The bill exempts life-threatening medical emergencies and prohibits prosecuting patients for violations. This legislation directly affects health care providers prescribing abortion drugs and pharmaceutical manufacturers, with penalties including felony charges for providers violating the requirements. The bill died in process in May 2025 and was never enacted.
SB 199 revises Montana's Medicaid expansion program (the Montana HELP Act) by introducing monthly "taxpayer integrity fees" for participants meeting specific asset thresholds. It requires fees based on excess real estate value ($5,000+ above homestead limits), vehicle equity ($20,000+ combined value), or agricultural land taxable value ($1,500+ annually), with a base fee of $100 plus $4 per $1,000 over limits. The bill also updates community engagement rules, mandating 80 monthly hours of work-related activities for 19-55-year-olds (with exemptions for medical conditions, caregivers, students, and others). These changes directly affect Medicaid expansion participants owning significant assets or required to meet work participation standards.
SB 112 would prohibit Montana state funds (including federal funds) from purchasing opioid reversal drugs after June 30, 2025, from companies involved in opioid settlement agreements. It allows existing contracts for these drugs to continue until fulfillment but bans renewal after the deadline, and requires continued supply under settlement agreements signed before September 1, 2024. The bill directly affects state agencies purchasing opioid reversal medications and pharmaceutical companies that settled opioid-related lawsuits. The bill died in committee in May 2025 and did not become law.
